COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH:

Key Record Dates Identifier: NCT01321541
Brief Title: Comparison of Pixantrone + Rituximab With Gemcitabine + Rituximab in Patients With Aggressive B-cell Non-Hodgkin Lymphoma or Follicular Grade 3 Lymphoma Who Have Relapsed After Therapy and Are Not Eligible for Stem Cell Transplant (PIX-R)

First Submitted : March 21, 2011
First Submitted that Met QC Criteria : March 22, 2011
First Posted : March 23, 2011 (Estimate)

Last Update Submitted that Met QC Criteria : October 16, 2018
Last Update Posted : October 17, 2018